Jun 09, 2014 7:00am EDT Can-Fite Subsidiary OphthaliX Provides an Update on its Clinical Developments and Strategic Plans
Jun 02, 2014 7:00am EDT Can-Fite Announces that the US FDA has Agreed with its Phase II Liver Cancer Protocol
May 07, 2014 11:41am EDT Can-Fite Receives Patent in European Union for Treatment of Liver Function Following Surgery
Apr 21, 2014 7:00am EDT Can-Fite Initiates the Development of an A3AR Biomarker Test Kit to Predict Patients' Response to Company's Drugs
